Novartis to exit India unit in $159 mln deal; Mumbai-listed shares surge 20% - Reuters
Novartis to exit India unit in $159 mln deal; Mumbai-listed shares surge 20% Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOLXJ6YWlYcmIyRDdRMjQ0SjhrNTFpQi0ySm5TRnFQdnhWZEY2MXpHUXY3RXM4b185Y01EalZDT3duNjNQNTVqcnMxRUJMaFUxVkNBZ1JpSmNYNlBLQWlKRmdsOS1zS0FmZVRpQW44MnlvUl9CekxOREZleUNLbFlZUmItZF90V2lyWU0xa0doZmNQWDg1dXZiOWJEYWFkQmgwZW1EQ2FxMF94c0xEQlZzLTJJNUFEYmtuV3c?oc=5" target="_blank">Novartis to exit India unit in $159 mln deal; Mumbai-listed shares surge 20%</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
IT leads rebound in Indian shares; TCS jumps on quarterly results - Reuters
IT leads rebound in Indian shares; TCS jumps on quarterly results Reuters
October 9, 2026 at 02:16 AMPfizer to cut around 330 jobs in Italy - Reuters
Pfizer to cut around 330 jobs in Italy Reuters
October 7, 2026 at 08:16 PMIndia's Aditya Birla unit seeks $1.5 billion in rupee loans to buy Shell arm Solenergi, bankers say - Reuters
India's Aditya Birla unit seeks $1.5 billion in rupee loans to buy Shell arm Solenergi, bankers say Reuters
October 9, 2026 at 06:08 AMIndian shares trim losses after hawkish RBI rate hike as financials rebound - Reuters
Indian shares trim losses after hawkish RBI rate hike as financials rebound Reuters
October 7, 2026 at 02:20 AMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMBASF considers raising offer for Evonik, sources say - Reuters
BASF considers raising offer for Evonik, sources say Reuters
October 9, 2026 at 02:02 PM